NCT06257264 - A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors | Biotech Hunter

Enrollment

218

Participants

Timeline

Start Date

March 11, 2024

Primary Completion Date

February 28, 2028

Study Completion Date

February 28, 2028

Conditions

Breast CancerSmall Cell Lung CancerOvarian CancerGastric CancerHormone-receptor-positive Breast CancerHormone Receptor Positive HER-2 Negative Breast CancerAdvanced Solid TumorEndometrial CancerProstate CancerTNBC - Triple-Negative Breast CancerGastroEsophageal CancerBladder Cancer

Interventions

DRUG

BG-68501

Planned doses administered orally.

DRUG

Fulvestrant

Standard dose administered via intramuscular injection.

DRUG

BGB-43395

Planned doses administered orally.

Trial Locations (33)

1023

RECRUITING

Auckland City Hospital, Auckland

2025

RECRUITING

The Institute of Oncology, Arensia Exploratory Medicine, Chisinau

10408

RECRUITING

National Cancer Center (Korea), IlsandongGu GoyangSi

13620

RECRUITING

Seoul National University Bundang Hospital, BundangGu SeongnamSi

75230

RECRUITING

Mary Crowley Cancer Research, Dallas

100021

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

100142

RECRUITING

Beijing Cancer Hospital, Beijing

110022

RECRUITING

Shengjing Hospital Affiliated of China Medical University, Shenyang

150000

RECRUITING

Harbin Medical University Cancer Hospital, Harbin

410013

RECRUITING

Hunan Cancer Hospital, Changsha

510245

RECRUITING

Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South), Guangzhou

610071

NOT_YET_RECRUITING

Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital, Chengdu

630014

NOT_YET_RECRUITING

The First Affiliated Hospital of Chongqing Medical University, Chongqing

710061

RECRUITING

The First Affiliated Hospital of Xian Jiaotong University, Xi'an

3109601

RECRUITING

Rambam Health Care Center, Haifa

9103102

RECRUITING

Shaare Zedek Medical Center, Jerusalem

92663-4162

RECRUITING

Hoag Memorial Presbyterian, Newport Beach

32746-2115

RECRUITING

Florida Cancer Specialists and Research Institute, Lake Mary

63110-1010

RECRUITING

Washington University School of Medicine, St Louis

08816-4096

RECRUITING

Titan Health Partners Llc Dba Astera Cancer Care, East Brunswick

57105-2108

RECRUITING

Avera Cancer Institute, Sioux Falls

NSW 2148

RECRUITING

Blacktown Cancer and Haematology Centre, Blacktown

NSW 2010

RECRUITING

Saint Vincents Hospital Sydney, Darlinghurst

NSW 2747

RECRUITING

Nepean Hospital, Kingswood

NSW 2065

RECRUITING

Genesiscare North Shore, St Leonards

QLD 4102

RECRUITING

Princess Alexandra Hospital, Woolloongabba

SA 5000

RECRUITING

Cancer Research South Australia, Adelaide

VIC 3168

RECRUITING

Monash Health, Clayton

VIC 3000

NOT_YET_RECRUITING

Peter Maccallum Cancer Centre, Melbourne

06351

RECRUITING

Samsung Medical Center, GangnamGu

03722

RECRUITING

Severance Hospital Yonsei University Health System, SeodaemunGu

03080

RECRUITING

Seoul National University Hospital, Seoul

05505

RECRUITING

Asan Medical Center, SongpaGu